RF
TAK icon

Rossby Financial’s Takeda Pharmaceutical TAK Stock Holding History

Rossby Financial’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$638 Buy
34
+17
+100% +$298 ﹤0.01% 2065
2025
Q4 		$265 Buy
+17
New +$243 ﹤0.01% 1727

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rossby Financial's TAK Position: Q1 2026 in Review

Rossby Financial increased its Takeda Pharmaceutical (TAK) stake by 100% in Q1 2026, buying an estimated $298 and bringing the position to 34 shares worth $638. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

Rossby Financial first reported a position in TAK in Q4 2025 and has held it in 2 quarters since. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Rossby Financial held 34 shares of Takeda Pharmaceutical worth $638 as of Q1 2026.
  • Rossby Financial bought 17 Takeda Pharmaceutical shares in Q1 2026, an estimated $298.
  • Takeda Pharmaceutical made up ﹤0.01% of Rossby Financial's portfolio in Q1 2026, its #2065 holding.
  • Rossby Financial first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 2 quarters since.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Rossby Financial's 13F filing for Q1 2026, filed 11 May 2026.